[ Inside the business ]

MRSH stock analysis

MRSH · Marsh & Mclennan Companies, Inc.

Insurance agents, brokers and service. Growing 8%.

Nothing unusual in its latest filings.

The future, in 7 questions

Priced in: 1.4× sales in 5 yrs. Evidence: sales +8% · 21¢ profit/$1.

01 What's priced in?1.4× sales in 5 yrs
Sales now$28.5B
Needed in 5 yrs$39.6B
Backlog$223M
02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Sales +8%, steady
No customer over 10%
Backlog $223M · under 0.1× salesPrepaid $1.0BSales +8%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 21¢ per $1
'21'22'23'24'2521¢
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares −0.5%/yrDebt $20.5B
07 What could break it?1 to watch
  • Moves strongly with the S&P 500

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth speeding up.

Sales growth +8%, +6%, then +8% vs. a year ago.

What could go wrong

Steadier than most.

It has moved 0.7× the market. In the 2008 crisis it fell 28% while the market fell 51%. Debt is heavy.

Speculative check

Self-funding.

Passes every condition: profitable, cash-generating and financially sound.

What they sell

Not broken out.

The filings don't split revenue by product in structured data.

Where each dollar goes

Not available.

Cost lines aren't reported in a comparable form.

Its market

1.0× the economy.

The government expects its industry, agencies, brokerages, and other insurance related activities, to grow 2.0% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Maturity.

It earns cash, still invests, and pays back more than it borrows.

Earnings quality

Can't score.

Not available: some of the eight inputs aren't in the company's structured filings (common for banks, insurers and companies without a cost of goods line).

Competitive advantage

10 of 10 years.

Returns beat its 7.3% cost of capital in 10 of the last 10 years.

Future bets

1% on equipment.

$320M a year on equipment and buildings.

All figures from Marsh & Mclennan Companies, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.